Publications related to TAT-Cx43

Single-nucleus RNA sequencing reveals a preclinical model for the most common subtype of glioblastoma

García-Vicente et al. Communications Biology 2025

Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis

Su et al. Nature Communications 2025

EGFR amplification and EGFRvIII predict and participate in TAT-Cx43_266-283 antitumor response in preclinical glioblastoma models

Álvarez-Vázquez et al. Neuro-Oncology 2024

A proteomic approach supports the clinical relevance of TAT-Cx43_266-283 in glioblastoma

G. Pelaz et al. Translational Research 2024

TAT-Cx43 selectively targets glioma cells and enhances survival in mouse models in vivo

Jaraíz-Rodríguez et al. Neuro-Oncology 2020

Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through Src

Pelaz et al. Ebiomedicine 2020

TAT-Cx43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src

Jaraíz-Rodríguez et al. Stem Cell Reports 2017

TAT-Cx43 reverses glioma stem cell phenotype

Gangoso et al. Cell Death and Disease 2014

Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes

González-Sánchez et al. Oncotarget 2016

Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells

Herrero-González et al. Oncogene 2010

Src: coordinating metabolism in cancer

Pelaz and Tabernero. Oncogene 2022

Connexins in cancer: bridging the gap to the clinic

Aasen et al. Oncogene 2019

The role of connexin43-Src interaction in astrocytomas: A molecular puzzle

Tabernero et al. Neuroscience 2016